ArticleTherapeutic advances in neurological disorders2009
Menstrual migraine: therapeutic approaches.
Article in Therapeutic advances in neurological disorders, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Perimenstrual repetitive greater occipital nerve blockade for menstrual migraine: a randomized, double-blind, placebo-controlled trial.BMC neurology · 2026Trial
- A Randomised, Double-Blind, Placebo-Controlled Crossover Trial of Resveratrol Supplementation for Prophylaxis of Hormonal Migraine.Nutrients · 2022Trial
- Efficacy and safety of erenumab in women with a history of menstrual migraine.The journal of headache and pain · 2020Trial
- Associations between Cerebrovascular Function and the Expression of Genes Related to Endothelial Function in Hormonal Migraine.International journal of molecular sciences · 2024Article
- Study to Determine the Prevalence of Menstrual Migraine in Reproductive-Age Women in Saudi Arabia.Healthcare (Basel, Switzerland) · 2024Article
- Exploring the effects of resveratrol supplementation on cerebrovascular function in hormonal migraineurs: A pilot study.IBRO neuroscience reports · 2023Article
- Study of the Mechanisms and Therapeutic Approaches of Migraine in Women and Pregnancy: A Literature Review.Cureus · 2023Review
- The impact of midlife on migraine in women: summary of current views.Women's midlife health · 2020Review
- The Relationship between the Phases of the Menstrual Cycle on the Incidence and Severity of Headache after Spinal Anesthesia.Surgery journal (New York, N.Y.) · 2019Article
- Women and Migraine: the Role of Hormones.Current neurology and neuroscience reports · 2018Review
- Burden of migraine related to menses: results from the AMPP study.The journal of headache and pain · 2015Article
- Menstrual migraine: treatment options.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2014Article
- Understanding migraine throughout a woman's life and the role of calcitonin gene-related peptide: A narrative review.Women's health (London, England)Review
Corrections and comments
- Erratum issued
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of diagnostic criteria has enabled greater recognition of menstrual migraine as a highly prevalent and disabling condition meriting specific treatment. Although few therapeutic trials have yet been undertaken in accordance with the criteria, the results of those published to date confirm the efficacy of acute migraine drugs for symptomatic treatment. If this approach is insufficient, the predictability of attacks provides the opportunity for perimenstrual prophylaxis. Continuous contraceptive strategies provide an additional option for management, although clinical trial data are limited. Future approaches to treatment could explore the genomic and nongenomic actions of sex steroids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.